Talis Biomedical Corporation (TLIS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Talis Biomedical Corporat...

OTC: TLIS · Real-Time Price · USD
1.06
-0.54 (-33.75%)
At close: Apr 04, 2025, 9:37 AM

Talis Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
76.73M 130.19M 232.54M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a 1.78M 767K
Other Long-Term Assets
1.54M 1.78M 5.51M
Receivables
50K 308K 183K
Inventory
n/a n/a n/a
Other Current Assets
901K 2.78M n/a
Total Current Assets
77.68M 133.28M 236.12M
Property-Plant & Equipment
15.45M 34.23M 23.43M
Goodwill & Intangibles
n/a -9.24M n/a
Total Long-Term Assets
16.99M 36.01M 29.71M
Total Assets
94.67M 169.29M 265.83M
Account Payables
1.34M 3.77M 5.12M
Deferred Revenue
n/a n/a 11.67M
Short-Term Debt
n/a 3.7M 1.23M
Other Current Liabilities
3.84M 509K 6.22M
Total Current Liabilities
8.77M 12.67M 19.11M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
16.79M 29.88M 12.74M
Total Liabilities
25.56M 42.55M 31.85M
Total Debt
19.67M 33.58M 13.98M
Common Stock
n/a 3K 3K
Retained Earnings
-539.96M -477.95M -364.94M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
69.12M 126.74M 233.98M
Total Investments
1.54M 1.78M 767K